BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 475 hits from CADENT THERAPEUTICS, INC.   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM237334
PNG
((3aR,5R,6aS)-5-benzyl-2- ((R)-2-(3-fluoro-4- hydro...)
Show SMILES O[C@@H](CN1C[C@H]2C[C@](O)(Cc3ccccc3)C[C@H]2C1)c1ccc(O)c(F)c1
Show InChI InChI=1/C22H26FNO3/c23-19-8-16(6-7-20(19)25)21(26)14-24-12-17-10-22(27,11-18(17)13-24)9-15-4-2-1-3-5-15/h1-8,17-18,21,25-27H,9-14H2/t17-,18+,21-,22-/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 0n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370772
PNG
(US10239835, Example 00324)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccc(F)cc1)c1ccc(O)cn1
Show InChI InChI=1/C20H23FN2O3/c21-15-1-4-17(5-2-15)26-18-7-13-10-23(11-14(13)8-18)12-20(25)19-6-3-16(24)9-22-19/h1-6,9,13-14,18,20,24-25H,7-8,10-12H2/t13-,14+,18+,20?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 4.41n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370754
PNG
(US10239835, Example 00306)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccccc1F)c1ccc(O)cc1
Show InChI InChI=1/C21H24FNO3/c22-19-3-1-2-4-21(19)26-18-9-15-11-23(12-16(15)10-18)13-20(25)14-5-7-17(24)8-6-14/h1-8,15-16,18,20,24-25H,9-13H2/t15-,16+,18+,20?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 4.44n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370814
PNG
(US10239835, Example 00365)
Show SMILES O[C@H](CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccccc1)c1ccc(O)cn1
Show InChI InChI=1/C20H24N2O3/c23-16-6-7-19(21-10-16)20(24)13-22-11-14-8-18(9-15(14)12-22)25-17-4-2-1-3-5-17/h1-7,10,14-15,18,20,23-24H,8-9,11-13H2/t14-,15+,18+,20-/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 5.24n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370813
PNG
(US10239835, Example 00364)
Show SMILES O[C@@H](CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccccc1)c1ccc(O)cn1
Show InChI InChI=1/C20H24N2O3/c23-16-6-7-19(21-10-16)20(24)13-22-11-14-8-18(9-15(14)12-22)25-17-4-2-1-3-5-17/h1-7,10,14-15,18,20,23-24H,8-9,11-13H2/t14-,15+,18+,20-/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 5.25n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370756
PNG
(US10239835, Example 00308)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccccc1)c1ccc(O)cn1
Show InChI InChI=1/C20H24N2O3/c23-16-6-7-19(21-10-16)20(24)13-22-11-14-8-18(9-15(14)12-22)25-17-4-2-1-3-5-17/h1-7,10,14-15,18,20,23-24H,8-9,11-13H2/t14-,15+,18+,20?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 5.72n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370745
PNG
(US10239835, Example 00297)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccccc1)c1ccc(O)cc1
Show InChI InChI=1/C21H25NO3/c23-18-8-6-15(7-9-18)21(24)14-22-12-16-10-20(11-17(16)13-22)25-19-4-2-1-3-5-19/h1-9,16-17,20-21,23-24H,10-14H2/t16-,17+,20+,21?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 5.96n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370743
PNG
(US10239835, Example 00295)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccccc1F)c1ccc(O)cn1
Show InChI InChI=1/C20H23FN2O3/c21-17-3-1-2-4-20(17)26-16-7-13-10-23(11-14(13)8-16)12-19(25)18-6-5-15(24)9-22-18/h1-6,9,13-14,16,19,24-25H,7-8,10-12H2/t13-,14+,16+,19?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 6.20n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370781
PNG
(US10239835, Example 00333)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccc(F)cc1F)c1ccc(O)cn1
Show InChI InChI=1/C20H22F2N2O3/c21-14-1-4-20(17(22)7-14)27-16-5-12-9-24(10-13(12)6-16)11-19(26)18-3-2-15(25)8-23-18/h1-4,7-8,12-13,16,19,25-26H,5-6,9-11H2/t12-,13+,16+,19?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 6.81n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370815
PNG
(US10239835, Example 00366)
Show SMILES O[C@@H](CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccccc1F)c1ccc(O)cn1
Show InChI InChI=1/C20H23FN2O3/c21-17-3-1-2-4-20(17)26-16-7-13-10-23(11-14(13)8-16)12-19(25)18-6-5-15(24)9-22-18/h1-6,9,13-14,16,19,24-25H,7-8,10-12H2/t13-,14+,16+,19-/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 8.30n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370816
PNG
(US10239835, Example 00367)
Show SMILES O[C@H](CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccccc1F)c1ccc(O)cn1
Show InChI InChI=1/C20H23FN2O3/c21-17-3-1-2-4-20(17)26-16-7-13-10-23(11-14(13)8-16)12-19(25)18-6-5-15(24)9-22-18/h1-6,9,13-14,16,19,24-25H,7-8,10-12H2/t13-,14+,16+,19-/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 8.5n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370769
PNG
(US10239835, Example 00321)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccc(F)cc1F)c1ccc(O)cc1
Show InChI InChI=1/C21H23F2NO3/c22-16-3-6-21(19(23)9-16)27-18-7-14-10-24(11-15(14)8-18)12-20(26)13-1-4-17(25)5-2-13/h1-6,9,14-15,18,20,25-26H,7-8,10-12H2/t14-,15+,18+,20?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 8.62n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370797
PNG
(US10239835, Example 00349)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1cccc(F)c1F)c1ccc(O)cn1
Show InChI InChI=1/C20H22F2N2O3/c21-16-2-1-3-19(20(16)22)27-15-6-12-9-24(10-13(12)7-15)11-18(26)17-5-4-14(25)8-23-17/h1-5,8,12-13,15,18,25-26H,6-7,9-11H2/t12-,13+,15+,18?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 8.78n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370802
PNG
(US10239835, Example 00354)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Sc1ccccc1)c1ccc(O)cc1
Show InChI InChI=1/C21H25NO2S/c23-18-8-6-15(7-9-18)21(24)14-22-12-16-10-20(11-17(16)13-22)25-19-4-2-1-3-5-19/h1-9,16-17,20-21,23-24H,10-14H2/t16-,17+,20+,21?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 9.36n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370768
PNG
(US10239835, Example 00320)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1c(F)cccc1F)c1ccc(O)cn1
Show InChI InChI=1/C20H22F2N2O3/c21-16-2-1-3-17(22)20(16)27-15-6-12-9-24(10-13(12)7-15)11-19(26)18-5-4-14(25)8-23-18/h1-5,8,12-13,15,19,25-26H,6-7,9-11H2/t12-,13+,15+,19?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 9.60n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370744
PNG
(US10239835, Example 00296)
Show SMILES Oc1ccc(cc1)C(=O)CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccccc1
Show InChI InChI=1/C21H23NO3/c23-18-8-6-15(7-9-18)21(24)14-22-12-16-10-20(11-17(16)13-22)25-19-4-2-1-3-5-19/h1-9,16-17,20,23H,10-14H2/t16-,17+,20+
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 10.7n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM237552
PNG
(US10052306, 223 | rac-(3aR,5r,6aS)-5-(4- chloroben...)
Show SMILES OC(CN1C[C@H]2C[C@](O)(Cc3ccc(Cl)cc3)C[C@H]2C1)c1ccc(O)cn1
Show InChI InChI=1/C21H25ClN2O3/c22-17-3-1-14(2-4-17)7-21(27)8-15-11-24(12-16(15)9-21)13-20(26)19-6-5-18(25)10-23-19/h1-6,10,15-16,20,25-27H,7-9,11-13H2/t15-,16+,20?,21-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 11.5n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM238867
PNG
(US10052306, 306 | rac-4-{2-[(3aR,5R,6aS)- 5-benzyl...)
Show SMILES OC(CN1C[C@@H]2C[C@@H](Cc3ccccc3)C[C@@H]2C1)c1ccc(O)cc1
Show InChI InChI=1/C22H27NO2/c24-21-8-6-18(7-9-21)22(25)15-23-13-19-11-17(12-20(19)14-23)10-16-4-2-1-3-5-16/h1-9,17,19-20,22,24-25H,10-15H2/t17-,19+,20-,22?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 11.7n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM238862
PNG
(US10052306, 301 | rac-4-{2-[(3aR,5S,6aS)- 5-benzyl...)
Show SMILES OC(CN1C[C@@H]2C[C@H](Cc3ccccc3)C[C@@H]2C1)c1ccc(O)c(F)c1
Show InChI InChI=1/C22H26FNO2/c23-20-11-17(6-7-21(20)25)22(26)14-24-12-18-9-16(10-19(18)13-24)8-15-4-2-1-3-5-15/h1-7,11,16,18-19,22,25-26H,8-10,12-14H2/t16-,18-,19+,22?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 12.2n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM237388
PNG
(US10052306, 204 | rac-(3aR,5r,6aS)-2-(2- hydroxy-2...)
Show SMILES OC(CN1C[C@H]2C[C@](O)(Cc3cccs3)C[C@H]2C1)c1ccc(O)cc1
Show InChI InChI=1/C20H25NO3S/c22-17-5-3-14(4-6-17)19(23)13-21-11-15-8-20(24,9-16(15)12-21)10-18-2-1-7-25-18/h1-7,15-16,19,22-24H,8-13H2/t15-,16+,19?,20-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 12.6n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370676
PNG
(US10239835, Example 00228)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccc(F)cc1)c1ccc(O)cc1
Show InChI InChI=1/C21H24FNO3/c22-17-3-7-19(8-4-17)26-20-9-15-11-23(12-16(15)10-20)13-21(25)14-1-5-18(24)6-2-14/h1-8,15-16,20-21,24-25H,9-13H2/t15-,16+,20+,21?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 13n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM238861
PNG
(US10052306, 300 | rac-4-(2-((3aR,6aS)-5- benzylhex...)
Show SMILES OC(CN1C[C@@H]2CC(Cc3ccccc3)C[C@@H]2C1)c1ccc(O)cc1
Show InChI InChI=1/C22H27NO2/c24-21-8-6-18(7-9-21)22(25)15-23-13-19-11-17(12-20(19)14-23)10-16-4-2-1-3-5-16/h1-9,17,19-20,22,24-25H,10-15H2/t17?,19-,20+,22?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 13.9n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370678
PNG
(US10239835, Example 00230)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccc(F)c(F)c1)c1ccc(O)cc1
Show InChI InChI=1/C21H23F2NO3/c22-19-6-5-17(9-20(19)23)27-18-7-14-10-24(11-15(14)8-18)12-21(26)13-1-3-16(25)4-2-13/h1-6,9,14-15,18,21,25-26H,7-8,10-12H2/t14-,15+,18+,21?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 14n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370782
PNG
(US10239835, Example 00334)
Show SMILES Cc1ccc(O[C@@H]2C[C@H]3CN(CC(O)c4ccc(O)cn4)C[C@H]3C2)c(F)c1
Show InChI InChI=1/C21H25FN2O3/c1-13-2-5-21(18(22)6-13)27-17-7-14-10-24(11-15(14)8-17)12-20(26)19-4-3-16(25)9-23-19/h2-6,9,14-15,17,20,25-26H,7-8,10-12H2,1H3/t14-,15+,17+,20?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 14.4n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM237683
PNG
(US10052306, 229 | rac-(3aR,5r,6aS)-5-(2- fluoroben...)
Show SMILES OC(CN1C[C@H]2C[C@](O)(Cc3ccccc3F)C[C@H]2C1)c1ccc(O)cc1
Show InChI InChI=1/C22H26FNO3/c23-20-4-2-1-3-16(20)9-22(27)10-17-12-24(13-18(17)11-22)14-21(26)15-5-7-19(25)8-6-15/h1-8,17-18,21,25-27H,9-14H2/t17-,18+,21?,22-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 15.5n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370755
PNG
(US10239835, Example 00307)
Show SMILES Oc1ccc(cc1)C(=O)CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccccc1F
Show InChI InChI=1/C21H22FNO3/c22-19-3-1-2-4-21(19)26-18-9-15-11-23(12-16(15)10-18)13-20(25)14-5-7-17(24)8-6-14/h1-8,15-16,18,24H,9-13H2/t15-,16+,18+
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 16.8n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM238865
PNG
(US10052306, 304 | rac-4-{2-[(3aR,5S,6aS)- 5-benzyl...)
Show SMILES OC(CN1C[C@@H]2C[C@H](Cc3ccccc3)C[C@@H]2C1)c1ccc(O)cc1
Show InChI InChI=1/C22H27NO2/c24-21-8-6-18(7-9-21)22(25)15-23-13-19-11-17(12-20(19)14-23)10-16-4-2-1-3-5-16/h1-9,17,19-20,22,24-25H,10-15H2/t17-,19-,20+,22?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 16.8n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM235335
PNG
(US10052306, 131 | US10052306, 281 | rac-(3aR,5r,6a...)
Show SMILES OC(CN1C[C@H]2C[C@](O)(Cc3ccccc3)C[C@H]2C1)c1ccc(O)cc1
Show InChI InChI=1/C22H27NO3/c24-20-8-6-17(7-9-20)21(25)15-23-13-18-11-22(26,12-19(18)14-23)10-16-4-2-1-3-5-16/h1-9,18-19,21,24-26H,10-15H2/t18-,19+,21?,22-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 17.4n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370727
PNG
(US10239835, Example 00279)
Show SMILES OC(CN1C[C@@H]2C[C@@H](C[C@@H]2C1)Oc1ccc(F)cc1)c1ccc(O)cc1
Show InChI InChI=1/C21H24FNO3/c22-17-3-7-19(8-4-17)26-20-9-15-11-23(12-16(15)10-20)13-21(25)14-1-5-18(24)6-2-14/h1-8,15-16,20-21,24-25H,9-13H2/t15-,16+,20-,21?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 17.8n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370681
PNG
(US10239835, Example 00233)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccc(F)c(F)c1)c1ccc(O)cn1
Show InChI InChI=1/C20H22F2N2O3/c21-17-3-2-15(7-18(17)22)27-16-5-12-9-24(10-13(12)6-16)11-20(26)19-4-1-14(25)8-23-19/h1-4,7-8,12-13,16,20,25-26H,5-6,9-11H2/t12-,13+,16+,20?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 17.8n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM237322
PNG
(US10052306, 168 | rac-(3aR,5r,6aS)-5-(4- fluoroben...)
Show SMILES OC(CN1C[C@H]2C[C@](O)(Cc3ccc(F)cc3)C[C@H]2C1)c1ccc(O)cn1
Show InChI InChI=1/C21H25FN2O3/c22-17-3-1-14(2-4-17)7-21(27)8-15-11-24(12-16(15)9-21)13-20(26)19-6-5-18(25)10-23-19/h1-6,10,15-16,20,25-27H,7-9,11-13H2/t15-,16+,20?,21-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 17.8n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370694
PNG
(US10239835, Example 00246)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1ccc(cc1)C#N)c1ccc(O)cn1
Show InChI InChI=1/C21H23N3O3/c22-9-14-1-4-18(5-2-14)27-19-7-15-11-24(12-16(15)8-19)13-21(26)20-6-3-17(25)10-23-20/h1-6,10,15-16,19,21,25-26H,7-8,11-13H2/t15-,16+,19+,21?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 18n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370809
PNG
(US10239835, Example 00361)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Sc1ccc(F)cc1)c1ccc(O)cc1
Show InChI InChI=1/C21H24FNO2S/c22-17-3-7-19(8-4-17)26-20-9-15-11-23(12-16(15)10-20)13-21(25)14-1-5-18(24)6-2-14/h1-8,15-16,20-21,24-25H,9-13H2/t15-,16+,20+,21?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 19.2n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM237551
PNG
(US10052306, 222 | rac-2-(2-(3-fluoro-4- hydroxyphe...)
Show SMILES OC(CN1C[C@H]2C[C@](O)(Cc3cccs3)C[C@H]2C1)c1ccc(O)c(F)c1
Show InChI InChI=1/C20H24FNO3S/c21-17-6-13(3-4-18(17)23)19(24)12-22-10-14-7-20(25,8-15(14)11-22)9-16-2-1-5-26-16/h1-6,14-15,19,23-25H,7-12H2/t14-,15+,19?,20-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 19.3n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370817
PNG
(US10239835, Example 00368)
Show SMILES O[C@@H](CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1cccnc1F)c1ccc(O)cn1
Show InChI InChI=1/C19H22FN3O3/c20-19-18(2-1-5-21-19)26-15-6-12-9-23(10-13(12)7-15)11-17(25)16-4-3-14(24)8-22-16/h1-5,8,12-13,15,17,24-25H,6-7,9-11H2/t12-,13+,15+,17-/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 20n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM238863
PNG
(US10052306, 302 | rac-4-{2-[(3aR,5R,6aS)- 5-benzyl...)
Show SMILES OC(CN1C[C@@H]2C[C@@H](Cc3ccccc3)C[C@@H]2C1)c1ccc(O)c(F)c1
Show InChI InChI=1/C22H26FNO2/c23-20-11-17(6-7-21(20)25)22(26)14-24-12-18-9-16(10-19(18)13-24)8-15-4-2-1-3-5-15/h1-7,11,16,18-19,22,25-26H,8-10,12-14H2/t16-,18+,19-,22?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 20.1n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM235341
PNG
((3aR,5S,6aS)-5-benzyl-2- ((S)-2-hydroxy-2-(4- hydr...)
Show SMILES O[C@H](CN1C[C@H]2C[C@](O)(Cc3ccccc3)C[C@H]2C1)c1ccc(O)cc1
Show InChI InChI=1/C22H27NO3/c24-20-8-6-17(7-9-20)21(25)15-23-13-18-11-22(26,12-19(18)14-23)10-16-4-2-1-3-5-16/h1-9,18-19,21,24-26H,10-15H2/t18-,19+,21-,22-/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 20.4n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM235341
PNG
((3aR,5S,6aS)-5-benzyl-2- ((S)-2-hydroxy-2-(4- hydr...)
Show SMILES O[C@H](CN1C[C@H]2C[C@](O)(Cc3ccccc3)C[C@H]2C1)c1ccc(O)cc1
Show InChI InChI=1/C22H27NO3/c24-20-8-6-17(7-9-20)21(25)15-23-13-18-11-22(26,12-19(18)14-23)10-16-4-2-1-3-5-16/h1-9,18-19,21,24-26H,10-15H2/t18-,19+,21-,22-/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 20.4n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370812
PNG
(US10239835, Example 00363)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Sc1ccccc1F)c1ccc(O)cn1
Show InChI InChI=1/C20H23FN2O2S/c21-17-3-1-2-4-20(17)26-16-7-13-10-23(11-14(13)8-16)12-19(25)18-6-5-15(24)9-22-18/h1-6,9,13-14,16,19,24-25H,7-8,10-12H2/t13-,14+,16+,19?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 20.6n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370749
PNG
(US10239835, Example 00301)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1cccnc1F)c1ccc(O)cn1
Show InChI InChI=1/C19H22FN3O3/c20-19-18(2-1-5-21-19)26-15-6-12-9-23(10-13(12)7-15)11-17(25)16-4-3-14(24)8-22-16/h1-5,8,12-13,15,17,24-25H,6-7,9-11H2/t12-,13+,15+,17?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 20.9n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370757
PNG
(US10239835, Example 00309)
Show SMILES OC(CN1C[C@@H]2C[C@H](C[C@@H]2C1)Oc1cccnc1F)c1ccc(O)c(F)c1
Show InChI InChI=1/C20H22F2N2O3/c21-16-8-12(3-4-17(16)25)18(26)11-24-9-13-6-15(7-14(13)10-24)27-19-2-1-5-23-20(19)22/h1-5,8,13-15,18,25-26H,6-7,9-11H2/t13-,14+,15+,18?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 21.7n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM237325
PNG
(US10052306, 171 | rac-(3aR,5r,6aS)-2-(2-(3- fluoro...)
Show SMILES OC(CN1C[C@H]2C[C@](O)(Cc3ccc(F)cc3)C[C@H]2C1)c1ccc(O)c(F)c1
Show InChI InChI=1/C22H25F2NO3/c23-18-4-1-14(2-5-18)8-22(28)9-16-11-25(12-17(16)10-22)13-21(27)15-3-6-20(26)19(24)7-15/h1-7,16-17,21,26-28H,8-13H2/t16-,17+,21?,22-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 22.1n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM238859
PNG
(US10052306, 298 | rac-6-(2-{5-benzyl- octahydrocyc...)
Show SMILES OC(CN1C[C@@H]2CC(Cc3ccccc3)C[C@@H]2C1)c1ccc(O)cn1
Show InChI InChI=1/C21H26N2O2/c24-19-6-7-20(22-11-19)21(25)14-23-12-17-9-16(10-18(17)13-23)8-15-4-2-1-3-5-15/h1-7,11,16-18,21,24-25H,8-10,12-14H2/t16?,17-,18+,21?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 22.4n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
GluN1/GluN2B NMDA receptor


(Homo sapiens (Human))
BDBM370784
PNG
(US10239835, Example 00336)
Show SMILES Cc1cccc(O[C@@H]2C[C@H]3CN(CC(O)c4ccc(O)cn4)C[C@H]3C2)c1F
Show InChI InChI=1/C21H25FN2O3/c1-13-3-2-4-20(21(13)22)27-17-7-14-10-24(11-15(14)8-17)12-19(26)18-6-5-16(25)9-23-18/h2-6,9,14-15,17,19,25-26H,7-8,10-12H2,1H3/t14-,15+,17+,19?
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 23.4n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
Cell Culture and plating: HEK293 cells expressing NR1/NR2B (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...


US Patent US10239835 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM235340
PNG
((3aR,5R,6aS)-5-benzyl-2- ((R)-2-hydroxy-2-(4- hydr...)
Show SMILES O[C@@H](CN1C[C@H]2C[C@](O)(Cc3ccccc3)C[C@H]2C1)c1ccc(O)cc1
Show InChI InChI=1/C22H27NO3/c24-20-8-6-17(7-9-20)21(25)15-23-13-18-11-22(26,12-19(18)14-23)10-16-4-2-1-3-5-16/h1-9,18-19,21,24-26H,10-15H2/t18-,19+,21-,22-/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 23.7n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM235340
PNG
((3aR,5R,6aS)-5-benzyl-2- ((R)-2-hydroxy-2-(4- hydr...)
Show SMILES O[C@@H](CN1C[C@H]2C[C@](O)(Cc3ccccc3)C[C@H]2C1)c1ccc(O)cc1
Show InChI InChI=1/C22H27NO3/c24-20-8-6-17(7-9-20)21(25)15-23-13-18-11-22(26,12-19(18)14-23)10-16-4-2-1-3-5-16/h1-9,18-19,21,24-26H,10-15H2/t18-,19+,21-,22-/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 23.7n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM237699
PNG
(US10052306, 245 | rac-5-(2,4- difluorobenzyl)-2-(2...)
Show SMILES OC(CN1C[C@H]2C[C@](O)(Cc3ccc(F)cc3F)C[C@H]2C1)c1ccc(O)cc1
Show InChI InChI=1/C22H25F2NO3/c23-18-4-1-15(20(24)7-18)8-22(28)9-16-11-25(12-17(16)10-22)13-21(27)14-2-5-19(26)6-3-14/h1-7,16-17,21,26-28H,8-13H2/t16-,17+,21?,22-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 23.8n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM237709
PNG
((3aR,5S,6aS)-5-(4- fluorobenzyl)-2-((S)-2- hydroxy...)
Show SMILES O[C@@H](CN1C[C@H]2C[C@](O)(Cc3ccc(F)cc3)C[C@H]2C1)c1ccc(O)cn1
Show InChI InChI=1/C21H25FN2O3/c22-17-3-1-14(2-4-17)7-21(27)8-15-11-24(12-16(15)9-21)13-20(26)19-6-5-18(25)10-23-19/h1-6,10,15-16,20,25-27H,7-9,11-13H2/t15-,16+,20-,21-/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 24n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM235335
PNG
(US10052306, 131 | US10052306, 281 | rac-(3aR,5r,6a...)
Show SMILES OC(CN1C[C@H]2C[C@](O)(Cc3ccccc3)C[C@H]2C1)c1ccc(O)cc1
Show InChI InChI=1/C22H27NO3/c24-20-8-6-17(7-9-20)21(25)15-23-13-18-11-22(26,12-19(18)14-23)10-16-4-2-1-3-5-16/h1-9,18-19,21,24-26H,10-15H2/t18-,19+,21?,22-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 25.5n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM237544
PNG
(US10052306, 215 | rac-2-(2-hydroxy-2-(5- hydroxypy...)
Show SMILES OC(CN1C[C@H]2C[C@](O)(Cc3cccs3)C[C@H]2C1)c1ccc(O)cn1
Show InChI InChI=1/C19H24N2O3S/c22-15-3-4-17(20-9-15)18(23)12-21-10-13-6-19(24,7-14(13)11-21)8-16-2-1-5-25-16/h1-5,9,13-14,18,22-24H,6-8,10-12H2/t13-,14+,18?,19-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 25.7n/an/an/an/an/an/a



CADENT THERAPEUTICS, INC.

US Patent


Assay Description
To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...


US Patent US10052306 (2018)


BindingDB Entry DOI: 10.7270/Q20R9RD3
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 475 total )  |  Next  |  Last  >>
Jump to: